BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 278 filers reported holding BLUEPRINT MEDICINES CORP in Q2 2021. The put-call ratio across all filers is 1.50 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $1,794,000 | -45.1% | 18,453 | -36.6% | 0.01% | -43.5% |
| Q4 2020 | $3,266,000 | +5.4% | 29,122 | -12.9% | 0.02% | +9.5% |
| Q3 2020 | $3,098,000 | +13.4% | 33,422 | -4.6% | 0.02% | -4.5% |
| Q2 2020 | $2,732,000 | +21.6% | 35,022 | -8.8% | 0.02% | +4.8% |
| Q1 2020 | $2,247,000 | -11.8% | 38,422 | +20.7% | 0.02% | +16.7% |
| Q4 2019 | $2,549,000 | -5.3% | 31,822 | -13.1% | 0.02% | +12.5% |
| Q3 2019 | $2,691,000 | -17.1% | 36,622 | +6.4% | 0.02% | -27.3% |
| Q2 2019 | $3,247,000 | +223.4% | 34,422 | +174.2% | 0.02% | +214.3% |
| Q1 2019 | $1,004,000 | +44.9% | 12,553 | -2.3% | 0.01% | +16.7% |
| Q4 2018 | $693,000 | -37.5% | 12,853 | -9.5% | 0.01% | -25.0% |
| Q3 2018 | $1,108,000 | +22.0% | 14,200 | -0.7% | 0.01% | +33.3% |
| Q2 2018 | $908,000 | -30.7% | 14,300 | 0.0% | 0.01% | -25.0% |
| Q1 2018 | $1,311,000 | – | 14,300 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 581,768 | $25,487,256 | 9.57% |
| Casdin Capital, LLC | 1,477,800 | $64,742,418 | 5.02% |
| Nextech Invest Ltd. | 188,228 | $8,246,269 | 3.28% |
| DAFNA Capital Management LLC | 261,235 | $11,444,705 | 3.22% |
| Rock Springs Capital Management LP | 1,891,510 | $82,867,053 | 1.99% |
| HealthCor Management, L.P. | 30,000 | $1,314,300 | 1.20% |
| EFG Asset Management (North America) Corp. | 110,853 | $4,766,679 | 1.07% |
| Novo Holdings A/S | 370,000 | $16,209,700 | 1.01% |
| SECTORAL ASSET MANAGEMENT INC | 115,900 | $5,077,579 | 0.98% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 305,709 | $13,393,111 | 0.83% |